文献速递男科与性医学

肾移植改善终末期肾病患者勃起功能:系统评价与Meta分析

Renal Transplantation Improves Erectile Function in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Urol · 2020-12-15

该系统评价与随机效应Meta分析纳入20项观察性研究、共1,695例肾移植受者,比较移植前后勃起功能。结果显示移植后勃起功能障碍人数减少(RR 1.21,95%CI 1.02-1.45),勃起功能改善(RR 2.53,95%CI 1.44-4.44),IIEF评分平均提高3.04分(95%CI 0.63-5.45);但敏感性分析未重现上述效应,证据质量多为低或极低。

要点

  • 肾移植后勃起功能障碍人数减少、IIEF评分平均提高3.04分。
  • 严重勃起功能障碍者未见肾移植的有利效应(RR 1.51,95%CI 0.85-2.68)。
  • 敏感性分析未重现主要效应,整体证据质量低或极低。

核心结论

  • 肾移植可改善勃起功能,术后勃起功能障碍风险较术前降低。
  • 严重勃起功能障碍患者未观察到肾移植的有利效应。
  • 证据多基于低质量数据,需标准化结局的更多研究验证。

研究设计与样本

  • 系统评价与随机效应Meta分析,比较肾移植受者术前与术后勃起功能(PROSPERO ID:CRD42020189580)。
  • 检索PubMed、Embase、Cochrane Library与Scopus自建库至2020年9月。
  • 纳入20项观察性研究,共1,695例肾移植受者。
  • 采用GRADE方法评价证据强度。

主要发现

  • 术后勃起功能障碍患者人数减少(RR 1.21,95%CI 1.02-1.45,I2=88%)。
  • 受者报告勃起功能改善(RR 2.53,95%CI 1.44-4.44,I2=90%)。
  • 移植后IIEF平均评分提高3.04分(95%CI 0.63-5.45,I2=96%)。
  • 上述效应在敏感性分析中未得到重现。
  • 严重勃起功能障碍者未见有利效应(RR 1.51,95%CI 0.85-2.68,I2=33%)。

关键数值与推荐

  • 所有结局的证据强度因方法学问题与高异质性被评为低或极低。
  • 纳入研究为观察性研究,检索截至2020年9月。

临床怎么用

  • 对终末期肾病拟行肾移植患者,可告知移植可能改善勃起功能。
  • 严重勃起功能障碍患者不应仅期待移植带来改善,需另行评估与处理。
  • 解读证据时应考虑其低质量与高异质性,谨慎用于临床决策。

局限性

  • 纳入研究均为观察性研究,存在方法学问题。
  • 各结局异质性高(I2最高达96%),敏感性分析未重现主要效应。
  • 证据强度总体为低或极低,需更多标准化结局研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Erectile dysfunction has a lower prevalence in renal transplant recipients compared to dialysis patients. Despite this observation, the effect of renal transplantation on erectile function remains unknown. We aimed to assess the role of renal transplantation on erectile function and to determine potential factors improving or deteriorating erectile dysfunction. MATERIALS AND METHODS: We conducted a systematic review and random effects meta-analysis of observational studies comparing erectile function preoperatively and postoperatively in renal transplant recipients (PROSPERO ID: CRD42020189580). Records reporting relevant outcomes were identified through search of PubMed®, Embase®, Cochrane Library and Scopus® databases from inception to September 2020. Judgment of the strength of evidence was performed with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. RESULTS: We included 20 studies with 1,695 renal transplant recipients. At postoperative evaluation the number of patients with erectile dysfunction was reduced (RR 1.21, 95% CI 1.02-1.45, I2=88%). Renal transplant recipients reported an improvement in erectile function (RR 2.53, 95% CI 1.44-4.44, I2=90%) and the mean International Index of Erectile Function score increased by 3.04 points (95% CI 0.63-5.45, I2=96%) after renal transplantation. These effects were not demonstrated in the sensitivity analysis. In individuals reporting severe erectile dysfunction, no favorable effect of renal transplantation was observed (RR 1.51, 95% CI 0.85-2.68, I2=33%). For all outcomes the strength of evidence was considered low or very low due to methodological concerns and high heterogeneity among the included studies. CONCLUSIONS: Renal transplantation improves erectile function and the risk of erectile dysfunction reduces postoperatively compared to preoperatively. However, evidence on the matter is mostly based on low quality data. More studies with standardized outcomes are needed to validate and strengthen our findings.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Pyrgidis N, Mykoniatis I, Sokolakis I, et al. Renal Transplantation Improves Erectile Function in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis. J Urol. 2020. PMID: 33320719. doi:10.1097/JU.0000000000001577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。